2,4-Bis{4-[(dialkylaminoalkyl)aminomethyl]phenyl}-7-substituted-7H-pyrrolo[2,3-d]pyrimidine Derivatives: Synthesis and Biological Evaluation as Novel Antiprotozoal Agents by Potentially Targeting G-Quadruplex
Abstract
Share and Cite
Guillon, J.; Savrimoutou, S.; Agnamey, P.; Milano, V.; Damiani, C.; Ronga, L.; Hanot, M.; Albenque, S.; Zangmo, T.; Monic, S.; et al. 2,4-Bis{4-[(dialkylaminoalkyl)aminomethyl]phenyl}-7-substituted-7H-pyrrolo[2,3-d]pyrimidine Derivatives: Synthesis and Biological Evaluation as Novel Antiprotozoal Agents by Potentially Targeting G-Quadruplex. Sci. Pharm. 2026, 94, 48. https://doi.org/10.3390/scipharm94020048
Guillon J, Savrimoutou S, Agnamey P, Milano V, Damiani C, Ronga L, Hanot M, Albenque S, Zangmo T, Monic S, et al. 2,4-Bis{4-[(dialkylaminoalkyl)aminomethyl]phenyl}-7-substituted-7H-pyrrolo[2,3-d]pyrimidine Derivatives: Synthesis and Biological Evaluation as Novel Antiprotozoal Agents by Potentially Targeting G-Quadruplex. Scientia Pharmaceutica. 2026; 94(2):48. https://doi.org/10.3390/scipharm94020048
Chicago/Turabian StyleGuillon, Jean, Solène Savrimoutou, Patrice Agnamey, Vittoria Milano, Céline Damiani, Luisa Ronga, Marie Hanot, Sandra Albenque, Tshering Zangmo, Sarah Monic, and et al. 2026. "2,4-Bis{4-[(dialkylaminoalkyl)aminomethyl]phenyl}-7-substituted-7H-pyrrolo[2,3-d]pyrimidine Derivatives: Synthesis and Biological Evaluation as Novel Antiprotozoal Agents by Potentially Targeting G-Quadruplex" Scientia Pharmaceutica 94, no. 2: 48. https://doi.org/10.3390/scipharm94020048
APA StyleGuillon, J., Savrimoutou, S., Agnamey, P., Milano, V., Damiani, C., Ronga, L., Hanot, M., Albenque, S., Zangmo, T., Monic, S., Pinaud, N., Lari, L., Marchivie, M., Moreau, S., Mergny, J.-L., Moukha, S., Dozolme, P., Boudot, C., Courtioux, B., ... Sonnet, P. (2026). 2,4-Bis{4-[(dialkylaminoalkyl)aminomethyl]phenyl}-7-substituted-7H-pyrrolo[2,3-d]pyrimidine Derivatives: Synthesis and Biological Evaluation as Novel Antiprotozoal Agents by Potentially Targeting G-Quadruplex. Scientia Pharmaceutica, 94(2), 48. https://doi.org/10.3390/scipharm94020048

